EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience

Ieuan Evans, Aaron Weimann, Timothy Baird, Charles Haworth, Andres Floto

Journal of Cystic Fibrosis · 2025-03 · 24 (2) · 364-367

DOI: 10.1016/j.jcf.2024.07.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025-03. Verfasst von Ieuan Evans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus is a multi-drug resistant species of non-tuberculous mycobacteria (NTM) that is increasingly emerging as a major threat to people with inflammatory lung diseases, such as cystic fibrosis (CF) [1-3]. Despite increased awareness of the issues faced by M. abscessus and recent publications of NTM-pulmonary disease (NTM-PD) treatment guidelines for people with CF (pwCF) in 2016 [4] and the ATS/ERS/ESCMID/IDSA guidelines in 2020 [5], the optimal treatment regimen for M. abscessus remains unclear and global treatment outcomes remain poor.

Autor:innen und Institutionen

  • Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia. Electronic address: Ieuan.Evans@health.qld.gov.…
  • Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Heart Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Department of Thoracic Medicine, Sunshine Coast University Hospital, Queensland, Australia.
  • Cambridge Centre for Lung Infection (CCLI), Royal Papworth Hospital, Cambridge, UK; Heart Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Cambridge Centre for Lung Infection (CCLI), Royal Papworth Hospital, Cambridge, UK; Heart Lung Research Institute, University of C…

Zitieren

APA

Evans, I., Weimann, A., Baird, T., Haworth, C., & Floto, A. (2025). Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience. Journal of Cystic Fibrosis, 24(2), 364-367. https://doi.org/10.1016/j.jcf.2024.07.016

Vancouver

Evans I, Weimann A, Baird T, Haworth C, Floto A. Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience. Journal of Cystic Fibrosis. 2025;24(2):364-367. doi:10.1016/j.jcf.2024.07.016

BibTeX
@article{Evans2025,
  author = {Evans, Ieuan and Weimann, Aaron and Baird, Timothy and Haworth, Charles and Floto, Andres},
  title = {Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  volume = {24},
  number = {2},
  pages = {364--367},
  doi = {10.1016/j.jcf.2024.07.016}
}
Kostenlos starten →